RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 62 filers reported holding RECRO PHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $9,714,000 | -25.7% | 1,050,115 | -27.9% | 5.82% | -24.4% |
| Q3 2017 | $13,073,000 | +1.6% | 1,455,818 | -20.4% | 7.71% | +10.9% |
| Q2 2017 | $12,863,000 | -48.8% | 1,829,669 | -36.3% | 6.95% | -50.9% |
| Q1 2017 | $25,122,000 | +8.4% | 2,874,317 | 0.0% | 14.16% | +2.6% |
| Q4 2016 | $23,167,000 | +123.9% | 2,874,317 | +145.5% | 13.80% | +63.5% |
| Q3 2016 | $10,348,000 | +203.6% | 1,170,600 | +173.1% | 8.44% | +141.5% |
| Q2 2016 | $3,408,000 | +141.0% | 428,670 | +81.0% | 3.49% | +109.5% |
| Q1 2016 | $1,414,000 | +34.4% | 236,874 | +102.6% | 1.67% | +35.4% |
| Q4 2015 | $1,052,000 | – | 116,901 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 1,104,546 | $11,233,000 | 5.38% |
| Broadfin Capital, LLC | 1,561,617 | $15,882,000 | 3.46% |
| Corsair Capital Management | 742,900 | $7,555,000 | 2.21% |
| NORTH RUN CAPITAL, LP | 315,338 | $3,207,000 | 2.18% |
| Fondren Management LP | 95,000 | $966,000 | 0.92% |
| Leap Investments LP | 25,611 | $260,000 | 0.35% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 213,002 | $2,166,000 | 0.30% |
| Campbell & CO Investment Adviser LLC | 38,989 | $397,000 | 0.18% |
| Opus Point Partners Management, LLC | 11,353 | $115,000 | 0.17% |
| Penn Capital Management Company, LLC | 149,946 | $1,525,000 | 0.15% |